These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 5795402)

  • 1. Therapy in congenital hyperbilirubinemia: phenobarbital and diethylnicotinamide.
    Ertel IJ; Newton WA
    Pediatrics; 1969 Jul; 44(1):43-8. PubMed ID: 5795402
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of transitory hyperbilirubinemia of the premature and mature newborn infants and of the hemolytic disease of the newborn by an enzyme induction combination: phenobarbital-nikethamide].
    Kintzel HW; Schwarze R; Hinkel GK
    Schweiz Med Wochenschr; 1972 Sep; 102(38):1339-45. PubMed ID: 4630163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug prevention of hyperbilirubinemia in newborn infants. 5. Cumulative effect of the combination of the inductors phenobarbital and nikethamide].
    Gmyrek D; Weh L; Kalz M; Bunke H; Cario WR; Lindenau E; Neumann R; Pietsch I; Scigalla P; Sima K; Syllm-Rapoport I
    Dtsch Gesundheitsw; 1972 Nov; 27(47):2221-7. PubMed ID: 4662684
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of toxic hyperbilirubinemia in premature and mature newborn infants by use of an enzyme-inducing combination: phenobarbital-nikethamide].
    Kintzel HW
    Helv Paediatr Acta; 1973; 30():Suppl:35-7. PubMed ID: 4711239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacologic treatment of a case of Crigler-Najjar syndrome].
    Lupi L; Di Tullio MT
    Pathologica; 1972; 64(931):223-6. PubMed ID: 4671380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preventive drug therapy of hyperbilirubinemia in full-term infants].
    Langer P; Berg G; Endig W
    Kinderarztl Prax; 1977 Jan; 45(1):11-4. PubMed ID: 556483
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synergistic effect of combined enzyme inductors (Phenobarbital and Nikethamide) on the bilirubin concentration in the serum of newborn infants].
    Kintzel HW; Schwarze R; Hinkel GK
    Dtsch Gesundheitsw; 1971 Dec; 26(51):2424-8. PubMed ID: 5148595
    [No Abstract]   [Full Text] [Related]  

  • 8. Congenital nonobstructive, nonhemolytic jaundice. Effect of phototherapy.
    Gorodischer R; Levy G; Krasner J; Jaffe SJ
    N Engl J Med; 1970 Feb; 282(7):375-7. PubMed ID: 5413103
    [No Abstract]   [Full Text] [Related]  

  • 9. [Crigler-Naijar syndrome. Clinical, biochemical, morphologic and therapeutic aspects].
    Götze H; Sidiropoulos D; Hess FA; Berthelot P
    Helv Paediatr Acta; 1972 Jul; 27(3):335-51. PubMed ID: 4645658
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenobarbital, hormones, and bilirubin.
    Crigler JF
    Johns Hopkins Med J; 1969 Nov; 125(5):245-9. PubMed ID: 5366122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phenobarbital in the treatment of hyperbilirubinemia of the newborn].
    Cao A; Fracassini F; Falorni A; Mastrantonio P
    Pediatria (Napoli); 1969; 77(1):177-88. PubMed ID: 5404931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phenobarbital therapy in congenital nonhemolytic hyperbilirubinemia (Crigler-Najjar)--report of 5 cases].
    Schellong G; Soennecken U
    Monatsschr Kinderheilkd (1902); 1971 Jul; 119(7):422-4. PubMed ID: 5093938
    [No Abstract]   [Full Text] [Related]  

  • 13. [New indications for phenobarbital in pediatrics].
    Windorfer A
    Med Welt; 1975 Aug; 6(35):1524-6. PubMed ID: 1177740
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilirubin binding and kernicterus.
    Diamond I
    Adv Pediatr; 1969; 16():99-119. PubMed ID: 4899063
    [No Abstract]   [Full Text] [Related]  

  • 15. Effective phototherapy in congenital nonobstructive, nonhemolytic jaundice.
    Karon M; Imach D; Schwartz A
    N Engl J Med; 1970 Feb; 282(7):377-80. PubMed ID: 5411133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of hyperbilirubinemia in premature infants using a combination of two enzyme inductors: phenobarbitol and nikethamide].
    Hinkel GK; Kintzel HW; Schwarze R; Händel A
    Dtsch Gesundheitsw; 1972 Sep; 27(39):1854-7. PubMed ID: 4634399
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital, nonhemolytic, unconjugated hyperbilirubinemia, and kernicterus.
    Crigler JF; Gold NI
    J Clin Invest; 1969 Jan; 48(1):42-55. PubMed ID: 5765026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency: evidence for genetic heterogeneity.
    Arias IM; Gartner LM; Cohen M; Ben-Ezzer J; Levi AJ
    Trans Assoc Am Physicians; 1968; 81():66-75. PubMed ID: 5729564
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of newborn infant hyperbilirubinemia by use of drugs. 8. Recommendation for the use of prevention in combination with a screening test for prognosis].
    Gmyrek D; Bunke H; Cario WR; Daberkow H; Läuter J; Saworra H; Weh L; Syllm-Rapoport I
    Kinderarztl Prax; 1973 Apr; 41(4):174-90. PubMed ID: 4731678
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of neonatal hyperbilirubinemia by enzyme inducers. Effectiveness of a phenobarbital-nikethamide association].
    Patriarca PL; Peracino A; Marcovina S; Zecca G
    Minerva Pediatr; 1975 Apr; 27(14):865-73. PubMed ID: 1134450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.